(Q43550159)

24 November 2017

title

(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis (English)

1 reference

24 November 2017

1 reference

1 reference

Luis L Ostrosky-Zeichner

series ordinal

4

object named as

Luis Ostrosky-Zeichner

1 reference

24 November 2017

Siraya Jaijakul

1

1 reference

24 November 2017

Jose A Vazquez

series ordinal

2

1 reference

24 November 2017

Robert N Swanson

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

9 May 2012

1 reference

Clinical Infectious Diseases

24 November 2017

published in

1 reference

24 November 2017

volume

55

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

521-526

1 reference

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Fungal ß(1,3)-D-glucan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

(1→3)β-d-Glucan Assay Positivity in Patients with Pneumocystis (carinii) jiroveci Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Beta -1,3 glucan as a test for central venous catheter biofilm infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

Serum (1→3) β‐D‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis and Follow‐Up ofPneumocystis jiroveciPneumonia in Patients with HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS456

21 January 2018

Identifiers

DOI

10.1093/CID/CIS456

1 reference

24 November 2017

1 reference